C
The startup manufactures catheter-delivered neurovascular implants that treat Intracranial Atherosclerotic Disease (ICAD) by mechanically opening blocked arteries caused by cholesterol plaque. This technology restores blood flow to the brain, improving symptoms associated with ICAD, such as stroke and cognitive decline.
Updated 3 months ago
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup manufactures catheter-delivered neurovascular implants that treat Intracranial Atherosclerotic Disease (ICAD) by mechanically opening blocked arteries caused by cholesterol plaque. This technology restores blood flow to the brain, improving symptoms associated with ICAD, such as stroke and cognitive decline.